Arvinas, Inc. (ARVN) has been beaten down lately with too much selling pressure. While the stock has lost 54% over the past four weeks, there is light at the end of the tunnel as it is now in ...

Despite a healthy cash balance, the ARVN's burn rate and lack of near-term catalysts make it an unattractive investment; reiterate sell rating. The press release provides scant detail ...

Elevai Labs has higher earnings, but lower revenue than Arvinas. Arvinas is trading at a lower price-to-earnings ratio than Elevai Labs, indicating that it is currently the more affordable of the ...